Drug |
---|
show drug details
| PubChem ID: | 5281051 |
---|
Structure: |  |
---|
Synonyms: | (component of) Hypericum spp (st. John's wort) | 1,3,4,6,8,13-Hexahydroxy-10,11-dimethylphenanthro [1,10,9,8-opqra]perylene-7,14-dione P-conformer | 1,3,4,6,8,13-Hexahydroxy-10,11-dimethylphenanthro(1,10,9,8-opqra)perylene- | 1,3,4,6,8,13-Hexahydroxy-10,11-dimethylphenanthro(1,10,9,8-opqra)perylene-7,14-dione | 1,3,4,6,8,13-hexahydroxy-10,11-dimethylphenanthro[1,10,9,8-opqra]perylene-7,14-dione | 1:6:8:10:11:13-hexahydroxy-3:4-dimethyl-meso-naphthodianthrene-7:14-dione | 4,5,7,4',5',7'-Hexahydroxy-2,2'-dimethyl-mesonapthtodianthron | 4,5,7,4',5',7'-Hexahydroxy-2,2'-dimethylnaphthodianthrone | 548-04-9 | 56690_FLUKA | 56690_SIGMA | AIDS-000117 | AIDS-052002 | AIDS000117 | AIDS052002 | Ambap348 | BiomolKI2_000040 | BiomolKI_000032 | C07606 | C30H16O8 | CHEBI:5835 | Cyclo werrol | Cyclo-Werol | Cyclosan | DRG-0113 | EINECS 208-941-0 | hipericina | HSCI1_000202 | Hypericin | Hypericin & Visible light | Hypericin from Hypericum perforatum | hypericine | Hypericum Extract | Hypericum red | Hyperizin | LMPK13040001 | LS-175574 | NCGC00162454-01 | NCGC00163378-01 | NCI60_003879 | NCI60_006799 | NSC 407313 | NSC 622946 | NSC407313 | NSC622946 | phenanthro[1,10,9,8-opqra]perylene-7,14-dione, 1,3,4,6,8,13-hexahydroxy-10,11-dimethyl- | Phenanthro[1,10,9,8-opqra]perylene-7,14-dione,1,3,4,6,8,13-hexahydroxy-10,11-dimethyl-, stereoisomer | VIMRxyn | ZINC03780340 |
|
---|
|
Target |
---|
show target details
| Uniprot ID: | DUOX1_HUMAN |
---|
Synonyms: | Dual oxidase 1 | Large NOX 1 | Long NOX 1 | NADPH thyroid oxidase 1 | Thyroid oxidase 1 |
|
---|
EC-Numbers: | 1.11.1.- 1.6.3.1
|
---|
Organism: | Homo sapiens Human
|
---|
PDB IDs: | - |
---|
|
Binding Affinities:Ki: | Kd: | Ic 50: | Ec50/Ic50: |
---|
- | - | - | - |
References:7487096 Inhibition of neutrophil superoxide generation by hypericin, an antiretroviral agent.. T Nishiuchi; T Utsumi; T Kanno; Y Takehara; H Kobuchi; T Yoshioka; A A Horton; T Yasuda; K Utsumi (1995) Archives of biochemistry and biophysics display abstractWe previously reported that phorbol 12-myristate 13-acetate (PMA)-induced superoxide (O2.-) generation of neutrophils was inhibited by hypericin, a photosensitizing pigment found in St. Johnswort (herb Hypericin triquetrifolium Turra), via a mechanism involving protein kinase C (PKC). To obtain further insights into the mechanism of inhibition, the effects of hypericin on stimulation-dependent O2.- generation and related enzymes of neutrophils were investigated. Hypericin inhibited O2.- generation of neutrophils induced by PKC-dependent and -independent stimuli in a light- and concentration-dependent manner. Oxygen was required for the light-dependent inhibition by hypericin. NADPH oxidase activity in a cell-free system and TNF-alpha-induced tyrosyl phosphorylation of neutrophil proteins were also inhibited by hypericin in a concentration- and light-dependent manner. However, tyrosine kinase of p60src, an enzyme not bound to a membrane, was not inhibited either in the light or in the dark. Oxygen uptake of neutrophils by photosensitization with hypericin resulted in the formation of singlet oxygen (1O2), O2.-, and hydroxyl radical (.OH) and enhanced lipid peroxidation. The formation of 1O2 was inhibited by azide, a quencher of 1O2, but not by desferrioxamine (DSF), a ferric ion chelator. By contrast, both generation of .OH and lipid peroxidation were inhibited by DSF but not by azide. Furthermore, PMA-induced O2.- generation inhibited by hypericin partially recovered in the presence of azide but not DSF. These results suggested that the light-dependent inhibition of O2.- generation by hypericin might be due to inhibition of tyrosine kinase, PKC, and NADPH oxidase via an oxygen-dependent mechanism, possibly through both Type I and II photosensitization mechanisms. |
|